Related Articles
Long‑term remission under Disitamab Vedotin (RC48) in HR‑positive/HER2‑positive metastatic breast cancer with brain meningeal, and bone marrow involvement: A case report
Development, efficacy and side effects of antibody‑drug conjugates for cancer therapy (Review)
Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells
Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model
Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report